A clinical case series of COVID-19-associated acute limb ischemia: real-world situation

Steven Philip Surya1, Rony Marethianto Santoso2

  • 1Primaya Hopsital Tangerang, Jl. MH. Thamrin no.3, Kebon Nanas, Cikokol, Tangerang, Indonesia. stevenphilip07@gmail.com.

Insights

This case series highlights acute limb ischemia (ALI) as a rare but serious complication of COVID-19. Management challenges and the importance of clinical follow-up in pandemic situations are emphasized.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Vascular Surgery

Background:

  • COVID-19 can lead to cardiovascular complications, including hypercoagulation and immunothrombus formation.
  • Acute Limb Ischemia (ALI) is a rare but organ-threatening complication of COVID-19.
  • Lack of specific guidelines for managing ALI in COVID-19 patients presents diagnostic and therapeutic challenges.

Purpose of the Study:

  • To present a case series of two patients experiencing acute limb ischemia secondary to COVID-19.
  • To discuss the challenges in diagnosing and managing ALI during the COVID-19 pandemic.
  • To underscore the importance of clinical follow-up for ALI patients with COVID-19.

Main Methods:

  • Case series presentation of two patients with ALI complicating COVID-19.
  • Detailed description of patient demographics, comorbidities, clinical presentation, and treatment.
  • Analysis of treatment outcomes and contributing factors.

Main Results:

  • The first patient, an 80-year-old female, recovered with oral drug therapy despite initial reluctance for hospitalization.
  • The second patient, a 54-year-old female with multiple comorbidities, unfortunately passed away due to acute respiratory distress syndrome.
  • Both patients presented with lower extremity pain and cyanosis, indicative of ALI.

Conclusions:

  • Treatment of ALI in COVID-19 patients is complicated by various internal and external factors.
  • Diagnosis and management of ALI in COVID-19 may deviate from standard guidelines due to hospital regulations.
  • Close clinical follow-up is crucial for effective management of ALI in the context of COVID-19.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
107
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
198
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
99
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
89
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
58
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
101